ABVC BioPharma, Inc. (ABVC)
0.9636
-0.03
(-2.87%)
USD |
NASDAQ |
Nov 12, 16:00
0.915
-0.05
(-5.04%)
After-Hours: 20:00
ABVC BioPharma Free Cash Flow (Quarterly) : -0.4389M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.4389M |
| June 30, 2026 | -0.2444M |
| March 31, 2026 | -0.8942M |
| December 31, 2025 | -0.5934M |
| September 30, 2025 | -0.9647M |
| June 30, 2025 | -0.8942M |
| March 31, 2025 | -0.5398M |
| December 31, 2024 | -0.2475M |
| September 30, 2024 | 0.0602M |
| June 30, 2024 | -0.2114M |
| March 31, 2024 | -0.9558M |
| December 31, 2023 | -0.5862M |
| September 30, 2023 | -0.8816M |
| June 30, 2023 | -0.8672M |
| March 31, 2023 | -1.873M |
| December 31, 2022 | -0.6426M |
| September 30, 2022 | -0.4957M |
| June 30, 2022 | -3.568M |
| March 31, 2022 | -3.052M |
| September 30, 2021 | -2.876M |
| June 30, 2021 | -1.447M |
| March 31, 2021 | -1.415M |
| December 31, 2020 | -4.226M |
| September 30, 2020 | 0.3267M |
| June 30, 2020 | -1.443M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.6997M |
| December 31, 2019 | -1.684M |
| September 30, 2019 | -0.444M |
| June 30, 2019 | -0.5689M |
| March 31, 2019 | -0.6114M |
| December 31, 2018 | -1.087M |
| September 30, 2018 | -0.2164M |
| June 30, 2018 | -0.3524M |
| March 31, 2018 | -0.5995M |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| December 31, 2016 | -0.2249M |
| September 30, 2016 | -0.2114M |
| June 30, 2016 | -2.834M |
| March 31, 2016 | 0.4454M |
| December 31, 2015 | -0.8743M |
| September 30, 2015 | -0.0031M |
| June 30, 2015 | 0.0023M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.0702M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 6.716M |
| Perspective Therapeutics, Inc. | -35.91M |
| MiMedx Group, Inc. | 3.598M |
| Abbott Laboratories | 1.224B |
| AngioDynamics, Inc. | -18.48M |